Kailos Genetics

Belkins
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions through identifying genetic risks to common medications. The Kailos test is an easily accessible genetic test catered to your lifestyle.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HOW DOES AVID BIOSERVICES INC (CDMO) STOCK COMPARE TO OTHERS IN BIOTECHNOLOGY?

InvestorsObserver | April 22, 2020

news image

Avid Bioservices Inc (CDMO) is around the top of the Biotechnology industry according to InvestorsObserver. CDMO received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Avid Bioservices Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 7 out of the 148 industries. What do These Ratings Mean? Finding the best stocks can be tricky. It isn’t easy to compare comp...

Read More

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

news image

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More

MEDICINAL GENOMICS ANNOUNCES NEW PATHOSEEK® ASPERGILLUS MULTIPLEX ASSAY TO STREAMLINE CANNABIS TESTING

BioSpace | February 27, 2020

news image

Medicinal Genomics (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus— A. flavus, A. fumigatus, A. niger, and A. terreus — on cannabis samples using just one qPCR reaction. This new Aspergillus assay is the first and only qPCR multiplex that can satisfy the Californ...

Read More

INDUSTRY OUTLOOK

CUROCELL, BREAKS GROUND ON 'CAR-T MANUFACTURING GMP FACILITY'

Curocell, Inc. | December 24, 2021

news image

Curocell, currently on PhaseⅠCAR-T Therapy clinical trial with CRC01 has recently broken ground for the new CAR-T Center in Dungok Residential & Industrial Area in Daejeon International Science & Business Belt. The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center. By the first half of 2023, construction is expected to be completed and...

Read More
news image

HOW DOES AVID BIOSERVICES INC (CDMO) STOCK COMPARE TO OTHERS IN BIOTECHNOLOGY?

InvestorsObserver | April 22, 2020

Avid Bioservices Inc (CDMO) is around the top of the Biotechnology industry according to InvestorsObserver. CDMO received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Avid Bioservices Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 7 out of the 148 industries. What do These Ratings Mean? Finding the best stocks can be tricky. It isn’t easy to compare comp...

Read More
news image

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More
news image

MEDICINAL GENOMICS ANNOUNCES NEW PATHOSEEK® ASPERGILLUS MULTIPLEX ASSAY TO STREAMLINE CANNABIS TESTING

BioSpace | February 27, 2020

Medicinal Genomics (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus— A. flavus, A. fumigatus, A. niger, and A. terreus — on cannabis samples using just one qPCR reaction. This new Aspergillus assay is the first and only qPCR multiplex that can satisfy the Californ...

Read More
news image

INDUSTRY OUTLOOK

CUROCELL, BREAKS GROUND ON 'CAR-T MANUFACTURING GMP FACILITY'

Curocell, Inc. | December 24, 2021

Curocell, currently on PhaseⅠCAR-T Therapy clinical trial with CRC01 has recently broken ground for the new CAR-T Center in Dungok Residential & Industrial Area in Daejeon International Science & Business Belt. The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center. By the first half of 2023, construction is expected to be completed and...

Read More